DK0934308T3 - 3-pyridyloxymethylheterocykliske etherforbindelser anvendelige til kontrollering af kemisk synaptisk transmission - Google Patents

3-pyridyloxymethylheterocykliske etherforbindelser anvendelige til kontrollering af kemisk synaptisk transmission

Info

Publication number
DK0934308T3
DK0934308T3 DK97927830T DK97927830T DK0934308T3 DK 0934308 T3 DK0934308 T3 DK 0934308T3 DK 97927830 T DK97927830 T DK 97927830T DK 97927830 T DK97927830 T DK 97927830T DK 0934308 T3 DK0934308 T3 DK 0934308T3
Authority
DK
Denmark
Prior art keywords
ether compounds
synaptic transmission
pyridyloxymethylheterocyclic
compounds useful
controlling chemical
Prior art date
Application number
DK97927830T
Other languages
Danish (da)
English (en)
Inventor
Nan-Horng Lin
Yun He
Mark W Holladay
Keith Ryther
Yihong Li
Hao Bai
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0934308T3 publication Critical patent/DK0934308T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK97927830T 1996-06-06 1997-06-04 3-pyridyloxymethylheterocykliske etherforbindelser anvendelige til kontrollering af kemisk synaptisk transmission DK0934308T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/660,044 US5629325A (en) 1996-06-06 1996-06-06 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
EP97927830A EP0934308B1 (fr) 1996-06-06 1997-06-04 Composes d'ethers 3-pyridyloxymethyle heterocycliques utilises dans la regulation de la transmission synaptique chimique

Publications (1)

Publication Number Publication Date
DK0934308T3 true DK0934308T3 (da) 2004-12-06

Family

ID=24647894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97927830T DK0934308T3 (da) 1996-06-06 1997-06-04 3-pyridyloxymethylheterocykliske etherforbindelser anvendelige til kontrollering af kemisk synaptisk transmission

Country Status (10)

Country Link
US (2) US5629325A (fr)
EP (1) EP0934308B1 (fr)
JP (2) JP4486712B2 (fr)
AT (1) ATE273296T1 (fr)
CA (1) CA2256022C (fr)
DE (1) DE69730229T2 (fr)
DK (1) DK0934308T3 (fr)
ES (1) ES2229364T3 (fr)
PT (1) PT934308E (fr)
WO (1) WO1997046554A1 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052497A1 (en) * 2000-03-09 2002-05-02 Targacept, Inc. Compounds capable of activating cholinergic receptors
US6979695B2 (en) * 1996-04-23 2005-12-27 Targacept, Inc. Compounds capable of activating cholinergic receptors
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
US6437138B1 (en) 1996-06-06 2002-08-20 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
DE69717148T2 (de) * 1996-12-10 2003-10-02 Abbott Laboratories, Abbott Park 3-pyridylenantiomere und ihre verwendung als analgetika
US6133253A (en) * 1996-12-10 2000-10-17 Abbott Laboratories 3-Pyridyl enantiomers and their use as analgesics
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
CA2306477A1 (fr) * 1997-11-05 1999-05-20 Neurosearch A/S Derives d'azacyclo-ether et leur utilisation en tant que modulateurs des recepteurs ach nicotiniques
DK1047690T3 (da) * 1997-12-19 2004-07-05 Abbott Lab Heterocykliske ether- og thioetherforbindelser, som er anvendelige til regulering af kemisk, synaptisk overförsel
AU2880699A (en) 1998-04-02 1999-10-25 R.J. Reynolds Tobacco Company Pharmaceutical compositions and methods for use
US6723838B1 (en) 1998-04-22 2004-04-20 Johns Hopkins University Signal transducing synaptic molecules and uses thereof
JP2002516904A (ja) 1998-06-03 2002-06-11 ジーピーアイ ニル ホールディングス インコーポレイテッド Ｎ−複素環式カルボン酸またはカルボン酸等配電子体のｎ−結合スルホンアミド
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
US20050131034A1 (en) * 1998-06-16 2005-06-16 Caldwell William S. Compounds capable of activating cholinergic receptors
US7790757B2 (en) * 1998-06-16 2010-09-07 Targacept, Inc. Compounds capable of activating cholinergic receptors
DE69919537T2 (de) * 1998-06-16 2005-09-08 Targacept, Inc. Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten
ATE273298T1 (de) * 1998-08-25 2004-08-15 Ortho Mcneil Pharm Inc Pyridyl-ether und -thioether als nikotin- acetylcholin-rezeptorliganden und ihre therapeutische anwendung
WO2000046193A2 (fr) * 1999-02-03 2000-08-10 Schering Aktiengesellschaft Derives d'ether
US6284779B1 (en) 1999-02-03 2001-09-04 Schering Aktiiengesellschaft Heteroaromatic compounds
US6833370B1 (en) * 1999-05-21 2004-12-21 Abbott Laboratories Heterocycle substituted aminoazacycles useful as central nervous system agents
US20010031771A1 (en) 1999-05-24 2001-10-18 Gary Maurice Dull Pharmaceutical compositions and methods for use
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
WO2001019817A2 (fr) * 1999-09-14 2001-03-22 Abbott Laboratories Composes d'ether 3-pyrrolidinyloxy-3'-pyridyle utilises comme regulateurs de la transmission synaptique chimique
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
ATE319712T1 (de) 1999-12-21 2006-03-15 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
US6277855B1 (en) 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
US6448276B1 (en) 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
US8124625B2 (en) * 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2470214A1 (fr) * 2001-12-13 2003-06-26 Abbott Laboratories Inhibiteurs de kinase
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
WO2003082191A2 (fr) * 2002-03-28 2003-10-09 Merck & Co., Inc. 2,3-diphenyl-pyridines substituees
US7098331B2 (en) 2003-03-05 2006-08-29 Targacept, Inc. Arylvinylazacycloalkane compounds and methods of preparation and use thereof
WO2005000806A2 (fr) * 2003-06-10 2005-01-06 Georgetown University Ligands pour les recepteurs de l'acetylcholine nicotinique, et procedes de production et d'utilisation de ces ligands
JP2007526324A (ja) * 2004-03-02 2007-09-13 スミスクライン・ビーチャム・コーポレイション Ａｋｔ活性のある阻害剤
AU2004318159B8 (en) * 2004-04-02 2011-05-26 Sahajanand Medical Technologies Private Limited Polymer-based stent assembly
CA2580329C (fr) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Administration de medicament transdermique biosynchrone
US9029557B2 (en) 2004-12-07 2015-05-12 The Regents Of The University Of California Labeled A4B2 ligands and methods therefor
WO2006086068A1 (fr) * 2004-12-07 2006-08-17 The Regents Of The University Of California Ligands de type alpha-4-beta-2 marques et procedes associes
GB0428514D0 (en) * 2004-12-31 2005-02-09 Prosidion Ltd Compounds
WO2006125641A2 (fr) * 2005-05-25 2006-11-30 Basf Aktiengesellschaft Composes de pyridine permettant de lutter contre les arthropodes nuisibles et les nematodes
US20090215857A1 (en) * 2005-09-13 2009-08-27 Pfizer Products Inc. Therapeutic Pyrrolidines
US20070184490A1 (en) * 2006-01-17 2007-08-09 Marleen Verlinden Neuronal nicotinic receptor ligands and their use
US20100069244A1 (en) * 2006-11-29 2010-03-18 Basf Se Pyridine Compounds for Combating Pests
EP2322167A1 (fr) 2007-04-02 2011-05-18 Parkinson's Institute Procédés et compositions pour la réduction des effets indésirables de traitements thérapeutiques
WO2008145681A2 (fr) * 2007-05-31 2008-12-04 Boehringer Ingelheim International Gmbh Antagonistes des récepteurs ccr2 et utilisations de ceux-ci
CN102112469B (zh) * 2008-05-23 2014-09-10 乔治敦大学 神经元nAChR的安静减敏剂及其使用方法
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
AU2009303545A1 (en) * 2008-10-14 2010-04-22 Psychogenics, Inc Nicotinic acetylcholine receptor ligands and the uses thereof
WO2010059393A1 (fr) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulateurs du récepteur de la sérotonine
US20100125094A1 (en) * 2008-11-17 2010-05-20 Auspex Pharmaceuticals, Inc. Pyrrolidinyl modulators of nicotinic acetylcholine receptors
JP2012512834A (ja) 2008-12-19 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 炎症、喘息及びｃｏｐｄの処置のためのｃｃｒ２受容体アンタゴニストとしての環状ピリミジン−４−カルボキサミド
EP2509982A1 (fr) 2009-12-07 2012-10-17 Targacept, Inc. 3,6-diazabicyclo[3.1.1]heptanes comme ligands des récepteurs nicotiniques neuronaux à l'acétycholine
PL3091012T3 (pl) 2009-12-17 2018-08-31 Centrexion Therapeutics Corporation Antagoniści receptora CCR2 i ich zastosowanie
US20130237550A1 (en) * 2010-03-11 2013-09-12 Targacept, Inc. Arylvinylazacycloalkane compounds for constipation
JP2013526507A (ja) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011144501A1 (fr) 2010-05-17 2011-11-24 Boehringer Ingelheim International Gmbh Antagonistes du récepteur ccr2 et leurs utilisations
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
JP5721242B2 (ja) * 2010-06-01 2015-05-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２アンタゴニスト
WO2012031220A2 (fr) 2010-09-03 2012-03-08 University Of Florida Research Foundation, Inc. Composés de nicotine et leurs analogues, procédés de synthèse pour fabriquer les composés et procédés d'utilisation
EP2731941B1 (fr) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Antagonistes ccr2, nouveaux et sélectifs
EP2776423B1 (fr) 2011-11-11 2020-05-06 Georgetown University Ligands nicotiniques substitués par un phényle, et leurs procédés d'utilisation
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2970177A1 (fr) 2013-03-15 2016-01-20 Pfizer Inc. Composés indoliques activant l'ampk
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
JP6917910B2 (ja) 2015-07-02 2021-08-11 セントレクシオン セラピューティクス コーポレイション （４−（（３ｒ，４ｒ）−３−メトキシテトラヒドロ−ピラン−４−イルアミノ）ピペリジン−１−イル）（５−メチル−６−（（（２ｒ，６ｓ）−６−（ｐ−トリル）テトラヒドロ−２ｈ−ピラン−２−イル）メチルアミノ）ピリミジン−４イル）メタノンクエン酸塩
EP3565617A1 (fr) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
WO2024146945A1 (fr) 2023-01-07 2024-07-11 Syngenta Crop Protection Ag Nouveaux composés pesticides à base de carboxamide et de sulfonamide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592866A (en) * 1982-09-30 1986-06-03 A. H. Robins Company, Inc. Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4956359A (en) * 1985-02-28 1990-09-11 A. H. Robins Company, Inc. 3-aryloxy and 3-arylthioazetidinecarboxamides as anticonvulsants and antiepileptics
DE3641343A1 (de) * 1986-12-03 1988-06-16 Hoechst Ag Carbamoylimidazol-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
EP0287908A3 (fr) * 1987-04-18 1989-12-27 ASTA Medica Aktiengesellschaft Composés cyclo-aliphatiques contenant de l'azote avec un reste d'acide aminé et une pyridine
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine
JPH0352887A (ja) * 1989-07-20 1991-03-07 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5278176A (en) * 1992-08-21 1994-01-11 Abbott Laboratories Nicotine derivatives that enhance cognitive function
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5472958A (en) * 1994-08-29 1995-12-05 Abbott Laboratories 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
US5703100A (en) * 1994-11-10 1997-12-30 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
IL118279A (en) * 1995-06-07 2006-10-05 Abbott Lab Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
US5629325A (en) * 1996-06-06 1997-05-13 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission

Also Published As

Publication number Publication date
DE69730229T2 (de) 2005-07-28
CA2256022C (fr) 2008-07-29
ATE273296T1 (de) 2004-08-15
ES2229364T3 (es) 2005-04-16
DE69730229D1 (de) 2004-09-16
EP0934308A1 (fr) 1999-08-11
JP2009256360A (ja) 2009-11-05
CA2256022A1 (fr) 1997-12-11
EP0934308B1 (fr) 2004-08-11
PT934308E (pt) 2004-11-30
JP4486712B2 (ja) 2010-06-23
US6127386A (en) 2000-10-03
US5629325A (en) 1997-05-13
WO1997046554A1 (fr) 1997-12-11
JP2002515038A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
DK0934308T3 (da) 3-pyridyloxymethylheterocykliske etherforbindelser anvendelige til kontrollering af kemisk synaptisk transmission
DK0663912T3 (da) Heterocykliske etherforbindelser til forstærkning af den kognitive funktion
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
DK0808304T3 (da) 2,3-substituerede pyridiner til behandling af inflammation
DK0808305T3 (da) 3,4-Diaryl-substituerede pyridiner til behandling af inflammation
EA199700061A1 (ru) Способ получения силденафила
BR9916396A (pt) Herbicidas
CY1113054T1 (el) Παραγωγα διαμινης
NO20011350L (no) 4-Karboksyaminosubstituerte 1,2,3,4-tetrahydrokinoliner som CETP inhibitorer
DK0732338T3 (da) 2,2-difluor-3-carbamoylribosesulfonatforbindelser og fremgangsmåde til fremstilling af beta-nucleosider
NO20011349L (no) 4-Aminosubstituerte 2-substituerte 1,2,3,4- tetrahydrokinoliner som CETP inhibitorer
DK0789578T3 (da) Inhibitorer af multikatalytisk protease
BR9711134A (pt) Composto e uso de um composto
DK1047690T3 (da) Heterocykliske ether- og thioetherforbindelser, som er anvendelige til regulering af kemisk, synaptisk overförsel
TR199901386T2 (en) �midazopiridazinler.
AP2001002045A0 (en) FKBP inhibitors.
DK1347984T3 (da) Fremgangsmåde til fremstilling af taxanderivater
ES2104509B1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
BR9902096A (pt) Pitazóis.
FI920095A0 (fi) Kontrollgivare foer sekundaer kylning av en maskin foer kontinuerlig gjutning, anpassningsstaong utrustad med saodana givare och foerfarande foer styrning av en maskin foer kontinuerlig gjutning.
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
WO2003044877A3 (fr) Dispositif electroluminescent et composes utilises dans celui-ci
IT247201Y1 (it) Gruppo proiettore
AR026673A1 (es) Benzoilpirazoles sustituidos por 3-(4,5-dihidroisoxazol-3-ilo)